534 related articles for article (PubMed ID: 29344635)
21. Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
Liu WL; Green N; Seymour LW; Stevenson M
Cancer Gene Ther; 2009 Oct; 16(10):764-75. PubMed ID: 19363466
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
Das S; Somasundaram K
Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
[TBL] [Abstract][Full Text] [Related]
23. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
24. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
25. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.
Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL
Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of TRAIL treatment against HPV16 infected cervical cancer cells undergoing senescence following siRNA knockdown of E6/E7 genes.
Eaton S; Wiktor P; Thirstrup D; Lake D; Nagaraj VJ
Biochem Biophys Res Commun; 2011 Feb; 405(1):1-6. PubMed ID: 21167816
[TBL] [Abstract][Full Text] [Related]
29. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
30. O-linked-N-acetylglucosamine transferase is associated with metastatic spread of human papillomavirus E6 and E7 oncoproteins to the lungs of mice.
Kim SH; Kim YS; Choi MY; Kim M; Yang JH; Park HO; Jang IS; Moon SH; Kim HO; Song DH; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi JY; Choi WS
Biochem Biophys Res Commun; 2017 Feb; 483(2):793-802. PubMed ID: 27845045
[TBL] [Abstract][Full Text] [Related]
31. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
32. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
33. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
Kim MS; Bak Y; Park YS; Lee DH; Kim JH; Kang JW; Song HH; Oh SR; Yoon DY
Cell Biol Toxicol; 2013 Aug; 29(4):259-72. PubMed ID: 23955116
[TBL] [Abstract][Full Text] [Related]
34. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
35. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.
Bai L; Wei L; Wang J; Li X; He P
Int J Gynecol Cancer; 2006; 16(2):718-29. PubMed ID: 16681752
[TBL] [Abstract][Full Text] [Related]
36. Attenuated Salmonella carrying plasmid co-expressing HPV16 L1 and siRNA-E6 for cervical cancer therapy.
Chen J; Zhao S; Tan W; Wang T; Wu S; Wang C; Jiang Y; Zhou T; Zhang Z; Zhao L
Sci Rep; 2021 Oct; 11(1):20083. PubMed ID: 34635698
[TBL] [Abstract][Full Text] [Related]
37. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
38. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
[TBL] [Abstract][Full Text] [Related]
39. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
40. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
